Vasundhara Rasy.

Who are the top shareholders of the Vasundhara Rasy.?

The top shareholder of Vasundhara Rasy is P & J Cretechem Private Limited, holding 61.98%, followed by Garg Leasing And Finance Private Limited at 3.55%, while individual investors own 30.05%. There are no mutual funds or foreign institutional investors in the company.

The top shareholders of Vasundhara Rasy include P & J Cretechem Private Limited, which holds the largest stake at 61.98%. The highest public shareholder is Garg Leasing And Finance Private Limited, with a holding of 3.55%. Additionally, individual investors collectively own 30.05% of the company. There are no mutual funds or foreign institutional investors currently holding shares in Vasundhara Rasy.

how big is Vasundhara Rasy.?

As of Jun 06, Vasundhara Rasayans Ltd has a market capitalization of 66.00 Cr, classifying it as a Micro Cap company, with recent net sales of 33.99 Cr and a net profit of 4.23 Cr. The latest balance sheet shows shareholder's funds of 31.94 Cr and total assets of 37.30 Cr.

Market Cap: As of Jun 06, Vasundhara Rasayans Ltd has a market capitalization of 66.00 Cr, which classifies it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest 4 quarters, the company reported Net Sales of 33.99 Cr and a Net Profit of 4.23 Cr. This data is based on Standalone financials.<BR><BR>Balance Sheet Snapshot: The Standalone balance sheet for the latest annual period, which is Mar'24, shows Shareholder's Funds of 31.94 Cr and Total Assets of 37.30 Cr.

What does Vasundhara Rasy. do?

Vasundhara Rasayans Ltd is a manufacturer and exporter of Antacids therapeutic category Active Pharmaceutical Ingredients in the Pharmaceuticals & Biotechnology industry. As of March 2025, it reported net sales of 8 Cr and a market cap of Rs 66 Cr.

Overview: <BR>Vasundhara Rasayans Ltd is a leading manufacturer and exporter of Antacids therapeutic category Active Pharmaceutical Ingredients, operating in the Pharmaceuticals & Biotechnology industry within the Micro Cap market segment.<BR><BR>History: <BR>Vasundhara Rasayans Ltd was incorporated in March 1987 and commenced operations in 1990 with an Antacid API facility. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 8 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 0 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: Rs 66 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 15.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 0.98% <BR>Debt-Equity: -0.04 <BR>Return on Equity: 11.90% <BR>Price to Book: 1.82<BR><BR>Contact Details: <BR>Address: Shed No 42 Phase II IDA, Mallapur Hyderabad Telangana : 500076 <BR>Tel: 91-40-23437617/23437623 <BR>Email: info@vrlindia.in <BR>Website: http://www.vasundhararasayans.in

Has Vasundhara Rasy. declared dividend?

Vasundhara Rasayans Ltd has declared a 20% dividend, amounting to ₹2 per share, with an ex-date of September 23, 2024. While the stock has shown strong long-term gains, recent performance reflects negative returns in the short term, and the dividend yield is relatively low at 0.98%.

Vasundhara Rasayans Ltd has declared a 20% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 20%<BR>- Amount per share: 2<BR>- Ex-date: 23 Sep 24<BR><BR>Dividend Yield: 0.98%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -27.93%, with a dividend return of 0%, resulting in a total return of -27.93%.<BR><BR>Over the past year, the price return was -7.7%, the dividend return was 0.87%, leading to a total return of -6.83%.<BR><BR>In the 2-year period, the price return was 30.53%, the dividend return was 2.57%, culminating in a total return of 33.1%.<BR><BR>During the last 3 years, the price return was 77.1%, with a dividend return of 4.75%, resulting in a total return of 81.85%.<BR><BR>For the 4-year period, the price return was 112.13%, the dividend return was 5.39%, which led to a total return of 117.52%.<BR><BR>In the 5-year span, the price return was 479.66%, with a dividend return of 16.81%, resulting in a total return of 496.47%.<BR><BR>Overall, while Vasundhara Rasayans Ltd has declared a dividend, the recent total returns indicate a mixed performance, with significant gains over longer periods but negative returns in the short term. The dividend yield is relatively low, suggesting that while dividends are being paid, the stock may not be performing strongly in the short run.

Who are the peers of the Vasundhara Rasy.?

Vasundhara Rasy.'s peers include Sun Pharma, Divi's Lab, Cipla, Torrent Pharma, Dr Reddy's Labs, Vivo Bio Tech, Roopa Industries, Medi Caps, and Dipna Pharmachem. Its 1-year return is -9.07%, lower than Vivo Bio Tech's -5.81%, with average management risk and good capital structure.

Peers: The peers of Vasundhara Rasy. are Sun Pharma.Inds., Divi's Lab., Cipla, Torrent Pharma, Dr Reddy's Labs, Vivo Bio Tech, Roopa Industries, Medi Caps, and Dipna Pharmachem.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sun Pharma.Inds., Divi's Lab., Cipla, Torrent Pharma, and Dr Reddy's Labs, while Average management risk is found at Vivo Bio Tech, Vasundhara Rasy., Medi Caps, and JFL Life. Below Average management risk is noted at Roopa Industries, and Dipna Pharmachem does not qualify. Growth is Excellent at Sun Pharma.Inds., Cipla, and Dr Reddy's Labs, while Below Average growth is seen at Divi's Lab., Torrent Pharma, Vivo Bio Tech, Vasundhara Rasy., Medi Caps, and the rest. Good growth is noted at Roopa Industries, while Dipna Pharmachem does not qualify. Capital Structure is Excellent at Sun Pharma.Inds., Divi's Lab., Cipla, and Dr Reddy's Labs, Good at Torrent Pharma and Vasundhara Rasy., while Average is found at Vivo Bio Tech and JFL Life, and Below Average at Roopa Industries and Medi Caps.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Divi's Lab. at 51.69%, while the lowest is Vivo Bio Tech at -5.81%. Vasundhara Rasy.'s 1-year return is -9.07%, which is lower than Vivo Bio Tech's. Additionally, the six-month return is negative for Vasundhara Rasy., Vivo Bio Tech, Medi Caps, and Torrent Pharma.

What is the technical trend for Vasundhara Rasy.?

As of May 23, 2025, Vasundhara Rasy's technical trend has shifted to a moderate bearish stance, supported by bearish signals from key indicators like the MACD, Bollinger Bands, and moving averages, along with significant underperformance compared to the Sensex.

As of 23 May 2025, the technical trend for Vasundhara Rasy has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. Key indicators driving this assessment include the weekly MACD and Bollinger Bands both indicating bearish conditions, along with daily moving averages also showing bearish signals. The KST is bearish on a weekly basis and mildly bearish monthly, while Dow Theory reflects a mildly bearish stance on the weekly and monthly time frames. The stock has underperformed significantly compared to the Sensex over various periods, particularly year-to-date and over the past year.

Who are in the management team of Vasundhara Rasy.?

As of March 2022, the management team of Vasundhara Rasy includes Sunil Jain Kumar, Sanjoy Kumar Jain, Rajesh Pokerna, Seema Jain, Manish Kumar Jain as executive directors, along with independent directors Pradeep Kumar Jain, Pravichandra Majumdar Popatlal, Rajiv Kakodkar, Manish Jain, and Ashish Kedia. This diverse team oversees the company's governance and strategic direction.

As of March 2022, the management team of Vasundhara Rasy includes the following individuals:<BR><BR>1. Sunil Jain Kumar - Executive Director / Whole Time Director<BR>2. Sanjoy Kumar Jain - Executive Director & Whole Time Director<BR>3. Rajesh Pokerna - Executive Director & Managing Director<BR>4. Seema Jain - Executive Director & Whole Time Director<BR>5. Pradeep Kumar Jain - Independent Non-Executive Director<BR>6. Pravichandra Majumdar Popatlal - Independent Non-Executive Director<BR>7. Rajiv Kakodkar - Independent Non-Executive Director<BR>8. Manish Jain - Independent Director<BR>9. Ashish Kedia - Independent Director<BR>10. Manish Kumar Jain - Whole-time Director<BR><BR>This team comprises a mix of executive and independent directors, contributing to the governance and strategic direction of the company.

How has been the historical performance of Vasundhara Rasy.?

Vasundhara Rasy has experienced fluctuating net sales and profits, peaking at 37.94 Cr in Mar'23 but declining to 33.99 Cr by Mar'25, alongside a decrease in profitability and negative cash flow trends. Despite an increase in total assets and liabilities, the company's operating profit margin and overall profitability have faced significant challenges.

Answer:<BR>The historical performance of Vasundhara Rasy shows a fluctuating trend in net sales and profits over the years, with a notable decline in recent periods.<BR><BR>Breakdown:<BR>Vasundhara Rasy's net sales peaked at 37.94 Cr in Mar'23 but fell to 33.99 Cr by Mar'25. The total operating income followed a similar trend, decreasing from 37.94 Cr in Mar'23 to 33.99 Cr in Mar'25. The raw material costs have remained relatively stable, with a slight increase from 15.53 Cr in Mar'24 to 15.63 Cr in Mar'25. Operating profit (PBDIT) also declined from 8.33 Cr in Mar'24 to 6.40 Cr in Mar'25, reflecting a decrease in operating profit margin from 17.26% to 11.92%. Profit before tax decreased from 7.90 Cr in Mar'24 to 5.77 Cr in Mar'25, while profit after tax dropped from 5.86 Cr to 4.25 Cr in the same period. The company's total assets increased from 37.30 Cr in Mar'24 to 43.07 Cr in Mar'25, alongside a rise in total liabilities from 37.30 Cr to 43.07 Cr. Cash flow from operating activities showed a negative trend, with a cash outflow of 5.00 Cr in Mar'25 compared to an inflow of 6.00 Cr in Mar'24. Overall, while Vasundhara Rasy has seen growth in total assets, its profitability and cash flow have faced challenges in recent years.

Is Vasundhara Rasy. overvalued or undervalued?

As of December 4, 2025, Vasundhara Rasy. is considered overvalued with a valuation grade of "expensive," a PE Ratio of 13.42, and a year-to-date return of -35.36%, significantly lagging behind its peers and the Sensex.

As of 4 December 2025, the valuation grade for Vasundhara Rasy. has moved from very expensive to expensive, indicating a shift in perception regarding its market valuation. The company is currently considered overvalued. Key ratios include a PE Ratio of 13.42, an EV to EBITDA of 14.79, and a ROE of 12.74%. <BR><BR>In comparison to peers, Vasundhara Rasy.'s PE Ratio is significantly lower than Solar Industries, which has a PE of 88.66, and Gujarat Fluoroch at 54.14. While Vasundhara Rasy. shows a PEG Ratio of 0.00, indicating no growth expectations, its current valuation does not align favorably with its peers in the Pharmaceuticals & Biotechnology sector. Additionally, the company's recent stock performance has lagged behind the Sensex, with a year-to-date return of -35.36% compared to the Sensex's 9.12%, further reinforcing the overvaluation narrative.

Should I buy, sell or hold Vasundhara Rasy.?

When is the next results date for Vasundhara Rasayans Ltd?

The next results date for Vasundhara Rasayans Ltd is 10 February 2026.

The next results date for Vasundhara Rasayans Ltd is scheduled for 10 February 2026.

Are Vasundhara Rasayans Ltd latest results good or bad?

Vasundhara Rasayans Ltd's latest results show strong profit growth with a 261.40% increase in net profit to ₹2.06 crores and an improved operating margin of 24.04%. However, revenue declined by 9.82% year-on-year to ₹8.82 crores, indicating challenges despite the positive profit performance.

The latest results for Vasundhara Rasayans Ltd present a mixed picture. On one hand, the company reported a significant increase in net profit for Q2 FY26, reaching ₹2.06 crores, which is a remarkable 261.40% increase quarter-on-quarter. This improvement is accompanied by a strong operating margin of 24.04%, a substantial rise from just 4.23% in the previous quarter. <BR><BR>However, the revenue figures tell a different story. The company generated ₹8.82 crores in revenue for Q2 FY26, which represents a 9.82% decline compared to the same quarter last year. While there was a sequential growth of 16.67% from the previous quarter, the year-on-year drop raises concerns about the sustainability of this growth.<BR><BR>Overall, while the profit margins and operational efficiency have improved significantly, the decline in revenue indicates underlying challenges that the company faces. This combination of strong profit growth alongside stagnating revenue suggests that while there are positive aspects, there are also serious concerns that need to be addressed. Therefore, the results can be seen as good in terms of profitability but bad in terms of revenue growth, reflecting a complex situation for the company.

Why is Vasundhara Rasayans Ltd falling/rising?

As of 08-May, Vasundhara Rasayans Ltd's stock price is rising to 130.85, reflecting a 0.27% increase. This rise is driven by strong recent performance compared to the Sensex, increased investor participation, and a bullish short-term trend, despite significant year-to-date and annual declines.

As of 08-May, Vasundhara Rasayans Ltd's stock price is rising, currently at 130.85, reflecting a change of 0.35 (0.27%) upward. This increase can be attributed to several factors. Firstly, the stock has outperformed the benchmark Sensex over the past week, with a gain of 1.20% compared to the Sensex's 0.54%. Additionally, the stock has shown a positive trend over the past month, rising by 4.10% while the Sensex has declined by 0.30%. <BR><BR>Investor participation has also increased, with a significant rise in delivery volume of 2.48 k on 07 May, which is up by 330.33% against the 5-day average. This surge in trading activity indicates growing interest among investors. Furthermore, the current price is higher than the 5-day and 50-day moving averages, suggesting a short-term bullish trend, although it remains below the 20-day, 100-day, and 200-day moving averages.<BR><BR>Despite the stock's year-to-date decline of 23.07% and a 1-year drop of 38.41%, the recent performance metrics and increased investor participation are contributing to the current rise in stock price.

Which are the latest news on Vasundhara Rasy.?